e-learning
resources
Virtual 2020
Monday, 07.09.2020
European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Why should we care for the vessels in interstitial lung disease?
H. Olschewski (Graz, Austria)
Source:
Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases
Session:
European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases
Session type:
Symposium
Number:
4007
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Olschewski (Graz, Austria). Why should we care for the vessels in interstitial lung disease?. Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
The value of a specialist nurse-lead interstitial lung disease clinic, patients’ views
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015
Palliative and symptomatic care of patients with fibrotic interstitial lung disease
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018
Are the gains due to pulmonary rehabilitation in idiopathic pulmonary fibrosis and other interstitial lung diseases the same?
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020
The management of children with interstitial lung disease
Source: International Congress 2018 – Difficult paediatric lung disease
Year: 2018
End-of-life care in in-patients dying from pulmonary fibrosis
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Pulmonary rehabilitation for interstitial lung disease
Source: ERS Course 2017
Year: 2017
Pulmonary rehabilitation in interstitial lung disease
Source: ERS Course 2020 - Pulmonary rehabilitation
Year: 2020
Intensive care outcomes in patients with diffuse fibrotic parenchymal lung diseases
Source: Annual Congress 2011 - Intensive care outcome
Year: 2011
A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Teleradiology in interstitial lung disease: first experiences
Source: International Congress 2017 – Rare diseases
Year: 2017
Patients profile and pulmonary rehabilitation in interstitial lung disease
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018
A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Palliative and end-of-life care for patients with respiratory disease
Source: Eur Respir Mon; 2009: 43:327–353
Year: 2009
Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities
Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options
Year: 2021
Investigation burden in patients with fibrotic interstitial lung disease in their terminal admission
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018
Review of care in patients dying of pulmonary fibrosis in a district general hospital
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Nitrofurantoin-induced interstitial lung disease
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012
Efficacy of pulmonary rehabilitation in patients with interstitial lung disease
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept